Government of India has made a major step to provide uninterrupted supply in difficult global conditions by amending the Morpholine (Quality Control) Order, 2020. Such update is indicative of a pragmatic manner of responding to supply chain disruption as well as protecting the continuity of industries.
Background of the Morpholine QCO
Morpholine (Quality Control) Order, 2020 was initially introduced with the provisions of the Bureau of Indian Standards Act, 2016. The aim of the order is to see that Morpholine, a common chemical in the industries like rubber, pharmaceuticals, and water treatment, is in accordance with the prescribed Indian Standards of quality and safety. Manufacturers and importers are normally required to comply with BIS standards, which guarantee reliability of products and consumer protection.
What Has Changed?
As per the latest notification dated 2nd April 2026, the Central Government has introduced a temporary relaxation in compliance requirements.
Key Amendment:
A proviso has been added stating that:
- Mandatory compliance with Indian Standards for Morpholine is suspended
- Applicable period: From 1st April 2026 to 1st July 2026
Reason Behind the Amendment
The decision has been taken considering:
- Ongoing global supply chain disruptions
- Risk of shortage in Morpholine availability
- Need to maintain industrial operations without interruption
After consultation with the Bureau of Indian Standards, the government determined that a temporary suspension is necessary in the public interest.
Impact on Industry Stakeholders1. Manufacturers & Importers
- Can supply Morpholine without BIS compliance during the specified period
- Relief from immediate certification requirements
- Opportunity to maintain production and distribution flow
2. End-User Industries
- Ensures continuous availability of raw materials
- Prevents operational slowdowns in key sectors
3. Compliance Strategy
- Businesses should treat this as a temporary relaxation
- Preparation for reinstatement of compliance post 1st July 2026 is critical
Important Considerations
- This is not a permanent exemption
- Quality assurance remains important despite regulatory relaxation
- Companies should continue aligning with BIS standards wherever feasible
Conclusion
Amendment of the Morpholine (Quality Control) Order, 2020 illustrates the adaptive nature of the government in regard to the global challenges through regulations. Although the temporary suspension is a welcome respite to industries, the businesses should be keen on ensuring compliance readiness upon the expiry of the relaxation period.
